Literature DB >> 10823854

Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.

H H Nguyen1, F W van Ginkel, H L Vu, M J Novak, J R McGhee, J Mestecky.   

Abstract

Heterosubtypic immunity (HSI) is defined as cross-protection against influenza virus of a different serotype than the virus initially encountered and is thought to be mediated by influenza virus-specific cytotoxic T lymphocytes (CTL). Since gamma interferon (IFN-gamma) stimulates cytotoxic cells, including antigen-specific CTL which may control virus replication by secretion of antiviral cytokines such as tumor necrosis factor alpha and IFN-gamma, we have investigated the mechanism of HSI by analyzing the role of IFN-gamma for HSI in IFN-gamma gene-deleted (IFN-gamma(-/-)) mice. It has been reported that IFN-gamma is not required for recovery from primary infection with influenza virus but is important for HSI. Here, we conclusively show that IFN-gamma is not required for induction of secondary influenza virus-specific CTL responses in mediastinal lymph nodes and HSI to lethal influenza A virus infection. Although T helper 2 (Th2)-type cytokines were upregulated in the lungs of IFN-gamma(-/-) mice after virus challenge, either Th1- or Th2-biased responses could provide heterosubtypic protection. Furthermore, titers of serum-neutralizing and cross-reactive antibodies to conserved nucleoprotein in IFN-gamma(-/-) mice did not differ significantly from those in immunocompetent mice. These results indicate that lack of IFN-gamma does not impair cross-reactive virus-specific immune responses and HSI to lethal infection with influenza virus. Our findings provide new insight for the mechanisms of HSI and should be valuable in the development of protective mucosal vaccines against variant virus strains, such as influenza and human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823854      PMCID: PMC112034          DOI: 10.1128/jvi.74.12.5495-5501.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

2.  The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes.

Authors:  K L Yap; G L Ada
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

3.  Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes.

Authors:  M A Wells; S Daniel; J Y Djeu; S C Kiley; F A Ennis
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

Review 4.  Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis.

Authors:  M Sarmiento; D P Dialynas; D W Lancki; K A Wall; M I Lorber; M R Loken; F W Fitch
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell.

Authors:  A G Morris; Y L Lin; B A Askonas
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

6.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

Authors:  R A Yetter; S Lehrer; R Ramphal; P A Small
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Cloning and expression of murine immune interferon cDNA.

Authors:  P W Gray; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

9.  Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.

Authors:  J R Klein; D H Raulet; M S Pasternack; M J Bevan
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.

Authors:  Y L Lin; B A Askonas
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Authors:  Maria E Lorenzo; Andrea Hodgson; Dionne P Robinson; Jenifer B Kaplan; Andrew Pekosz; Sabra L Klein
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

3.  Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.

Authors:  Jennifer Humberd Smith; Tamas Nagy; Jamie Barber; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

4.  Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms.

Authors:  K Kai McKinstry; Tara M Strutt; Yi Kuang; Deborah M Brown; Stewert Sell; Richard W Dutton; Susan L Swain
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 5.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

6.  Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production.

Authors:  Sean R McMaster; Jarad J Wilson; Hong Wang; Jacob E Kohlmeier
Journal:  J Immunol       Date:  2015-05-29       Impact factor: 5.422

7.  Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.

Authors:  Shamaila Ashraf; Wei Kong; Shifeng Wang; Jiseon Yang; Roy Curtiss
Journal:  Vaccine       Date:  2011-04-03       Impact factor: 3.641

8.  Critical role of IL-17RA in immunopathology of influenza infection.

Authors:  Christopher R Crowe; Kong Chen; Derek A Pociask; John F Alcorn; Cameron Krivich; Richard I Enelow; Ted M Ross; Joseph L Witztum; Jay K Kolls
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

9.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

10.  Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

Authors:  Fu-Shi Quan; Richard W Compans; Huan H Nguyen; Sang-Moo Kang
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.